One capsule of Osteotriol a day can not say whether it is good or not, the specific dosage needs to be adjusted according to the patient’s type of disease as well as physical fitness.
Osteotriol is a vitamin preparation, which is the main drug for the treatment of osteoporosis in the elderly; the initial level of osteotriol is 0.25 μg, which is once a day, but if there is no monitoring of the blood calcium level, the drug should not be added blindly; 0.25 μG1 capsule/day can be used in senile osteoporosis, 3 times/day, and the blood calcium level should be monitored after 2~4 weeks of administration.
Hypercalcemia syndrome or calcium toxicity may occur with the use of this product, with occasional anorexia, headache, nausea, vomiting, abdominal or epigastric pain, and constipation; chronic adverse reactions such as muscle weakness, weight loss, impaired consciousness, fever, thirst, polyuria, dehydration, growth retardation, and urinary tract infections may also occur.
Please pay attention to blood calcium and blood urea tests during the administration of the drug; in patients with renal failure, it is necessary to prevent the risk caused by abnormal calcium precipitation; this product is prohibited for use in diseases associated with hypercalcemia, in patients who are hypersensitive to this product or to similar drugs and to any excipients, and in patients with symptoms of vitamin D toxicity.
Therefore, the drug needs to be taken under the direction of a doctor and should not be taken without authorization, and in the event of a serious adverse reaction should be promptly consulted.